The ever-increasing threat from superbugs strains of pathogenic bacteria that are impervious to the antibiotics that subdued their predecessor generations has forced the medical community to look for bactericidal weapons outside the realm of traditional drugs. One promising candidate is the antimicrobial peptide (AMP), one of Mother Natures lesser-known defenses against infections, that kills a pathogen by creating, then expanding, nanometer-sized pores in the cell membrane until it bursts. However, before this phenomenon can be exploited as a medical therapy, researchers need a better understanding of how AMPs and membranes interact at the molecular level.
Using a novel imaging technique, a research team led by the United Kingdoms National Physical Laboratory (NPL) is helping acquire much-needed insight into the fundamental physical and chemical processes that occur when AMPs bind with membranes and form pores in them. Team leader Paulina D. Rakowska discussed the latest aspects of this work during the AVS 60th International Symposium & Exhibition, held Oct. 27-Nov. 1, 2013 in Long Beach, Calif.
Observing the formation of pores in live cell membranes by naturally occurring AMPs is difficult because researchers have no control over the steps in the complex process. In many cases, the membranes of the target cell leak, swell and rupture before individual pores can expand enough to be examined. Rakowska and her colleagues have overcome this obstacle by combining nanoscale imaging via two different systems, computer simulation, a made-from-scratch (de novo) AMP, and lipid bilayers fixed to a solid surface (known as a supported lipid bilayer or SLB).
With the ability to specifically test where and how the de novo peptide binds to the SLB, the pore formation process is opened up to direct observation. Atomic force microscopy (AFM) provides topographical (structural) imaging of the peptide-treated membrane while chemical analysis is done with high-resolution nanoscale secondary ion mass spectroscopy (NanoSIMS).
Data from the AFM images suggests that membranes change as a result of peptide action and pore formation, Rakowska says. NanoSIMS imaging performed on the same samples reveal the precise location of peptide molecules within the membranes.
Rakowska says that these observations provide the first-ever physical and visual evidence of antimicrobial pore expansion from nano-to-micrometer scale to the point of complete membrane disintegration. We can now postulate the mechanism by which this occurs, she explains. We believe that the first AMPs binding with the membrane actively recruit others to do the same, resulting in the formation of numerous small pores. As these pores expand, they eventually lead to membrane disintegration and cell death.
The research team includes scientists from the NPL, the London Centre for Nanotechnology, University College London, the University of Oxford, the University of Edinburgh, Freie University Berlin and IBM. The teams latest publication, Nanoscale imaging reveals laterally expanding antimicrobial pores in lipid bilayers, recently appeared in the Proceedings of the National Academy of Sciences USA.
Source: AVS
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
What Lies Beneath: Why Borescopes Are Essential for Verifying Surgical Instrument Cleanliness
July 16th 2025Despite their smooth, polished exteriors, surgical instruments often harbor dangerous contaminants deep inside their lumens. At the HSPA25 and APIC25 conferences, Cori L. Ofstead, MSPH, and her colleagues revealed why borescopes are an indispensable tool for sterile processing teams, offering the only reliable way to verify internal cleanliness and improve sterile processing effectiveness to prevent patient harm.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
Targeting Uncertainty: Why Pregnancy May Be the Best Time to Build Vaccine Confidence
July 15th 2025New national survey data reveal high uncertainty among pregnant individuals—especially first-time parents—about vaccinating their future children, underscoring the value of proactive engagement to strengthen infection prevention.